Diagnos Days Sales Outstanding vs Capex To Depreciation Analysis

ADK Stock  CAD 0.29  0.01  3.57%   
Diagnos financial indicator trend analysis is much more than just examining Diagnos latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Diagnos is a good investment. Please check the relationship between Diagnos Days Sales Outstanding and its Capex To Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Diagnos. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Days Sales Outstanding vs Capex To Depreciation

Days Sales Outstanding vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Diagnos Days Sales Outstanding account and Capex To Depreciation. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Diagnos' Days Sales Outstanding and Capex To Depreciation is 0.13. Overlapping area represents the amount of variation of Days Sales Outstanding that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Diagnos, assuming nothing else is changed. The correlation between historical values of Diagnos' Days Sales Outstanding and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Days Sales Outstanding of Diagnos are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Days Sales Outstanding i.e., Diagnos' Days Sales Outstanding and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

0.13
Relationship DirectionPositive 
Relationship StrengthInsignificant

Days Sales Outstanding

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.
Most indicators from Diagnos' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Diagnos current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Diagnos. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Diagnos' Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to climb to about 1.1 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (9.87) in 2024.
 2021 2022 2023 2024 (projected)
Total Revenue438.8K485.7K170.2K161.7K
Depreciation And Amortization101.2K124.2K142.8K118.2K

Diagnos fundamental ratios Correlations

-0.30.61-0.27-0.440.16-0.50.480.010.120.930.34-0.18-0.23-0.340.97-0.39-0.160.35-0.270.420.68-0.31-0.080.39-0.13
-0.3-0.790.090.79-0.130.31-0.32-0.19-0.07-0.40.48-0.130.110.83-0.250.790.50.070.94-0.03-0.310.55-0.08-0.480.53
0.61-0.79-0.32-0.970.34-0.380.5-0.18-0.230.74-0.2-0.07-0.34-0.940.64-0.95-0.390.03-0.70.340.57-0.87-0.060.69-0.57
-0.270.09-0.320.33-0.560.35-0.440.570.11-0.34-0.260.530.640.3-0.40.32-0.2-0.320.0-0.6-0.130.360.63-0.38-0.1
-0.440.79-0.970.33-0.380.27-0.540.270.29-0.590.240.090.370.96-0.490.970.40.040.68-0.34-0.390.890.09-0.660.62
0.16-0.130.34-0.56-0.380.270.17-0.050.150.130.21-0.91-0.97-0.280.16-0.360.22-0.16-0.110.660.13-0.38-0.910.12-0.1
-0.50.31-0.380.350.270.27-0.310.310.27-0.630.17-0.29-0.190.31-0.560.270.16-0.590.24-0.18-0.440.23-0.24-0.21-0.2
0.48-0.320.5-0.44-0.540.17-0.31-0.38-0.070.480.34-0.17-0.27-0.430.56-0.43-0.280.38-0.190.59-0.13-0.32-0.170.36-0.28
0.01-0.19-0.180.570.27-0.050.31-0.380.77-0.19-0.06-0.050.090.22-0.220.24-0.27-0.14-0.29-0.20.020.420.01-0.25-0.15
0.12-0.07-0.230.110.290.150.27-0.070.77-0.190.43-0.38-0.170.32-0.060.29-0.190.21-0.20.06-0.220.52-0.3-0.14-0.1
0.93-0.40.74-0.34-0.590.13-0.630.48-0.19-0.190.07-0.02-0.18-0.530.95-0.56-0.10.24-0.340.360.79-0.530.010.49-0.1
0.340.48-0.2-0.260.240.210.170.34-0.060.430.07-0.52-0.330.380.340.280.090.480.390.42-0.230.27-0.38-0.040.0
-0.18-0.13-0.070.530.09-0.91-0.29-0.17-0.05-0.38-0.02-0.520.91-0.04-0.160.04-0.2-0.11-0.13-0.740.050.070.940.050.0
-0.230.11-0.340.640.37-0.97-0.19-0.270.09-0.17-0.18-0.330.910.29-0.250.36-0.160.020.07-0.73-0.110.380.94-0.150.11
-0.340.83-0.940.30.96-0.280.31-0.430.220.32-0.530.38-0.040.29-0.380.980.430.080.72-0.22-0.420.910.04-0.680.63
0.97-0.250.64-0.4-0.490.16-0.560.56-0.22-0.060.950.34-0.16-0.25-0.38-0.43-0.090.37-0.20.450.66-0.4-0.080.44-0.09
-0.390.79-0.950.320.97-0.360.27-0.430.240.29-0.560.280.040.360.98-0.430.350.070.73-0.24-0.440.920.08-0.680.61
-0.160.5-0.39-0.20.40.220.16-0.28-0.27-0.19-0.10.09-0.2-0.160.43-0.090.35-0.370.37-0.140.10.26-0.27-0.410.78
0.350.070.03-0.320.04-0.16-0.590.38-0.140.210.240.48-0.110.020.080.370.07-0.370.10.44-0.120.11-0.03-0.01-0.02
-0.270.94-0.70.00.68-0.110.24-0.19-0.29-0.2-0.340.39-0.130.070.72-0.20.730.370.10.12-0.320.44-0.11-0.430.45
0.42-0.030.34-0.6-0.340.66-0.180.59-0.20.060.360.42-0.74-0.73-0.220.45-0.24-0.140.440.120.01-0.3-0.710.1-0.13
0.68-0.310.57-0.13-0.390.13-0.44-0.130.02-0.220.79-0.230.05-0.11-0.420.66-0.440.1-0.12-0.320.01-0.480.060.370.03
-0.310.55-0.870.360.89-0.380.23-0.320.420.52-0.530.270.070.380.91-0.40.920.260.110.44-0.3-0.480.12-0.680.57
-0.08-0.08-0.060.630.09-0.91-0.24-0.170.01-0.30.01-0.380.940.940.04-0.080.08-0.27-0.03-0.11-0.710.060.120.06-0.06
0.39-0.480.69-0.38-0.660.12-0.210.36-0.25-0.140.49-0.040.05-0.15-0.680.44-0.68-0.41-0.01-0.430.10.37-0.680.06-0.6
-0.130.53-0.57-0.10.62-0.1-0.2-0.28-0.15-0.1-0.10.00.00.110.63-0.090.610.78-0.020.45-0.130.030.57-0.06-0.6
Click cells to compare fundamentals

Diagnos Account Relationship Matchups

Diagnos fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.4M2.0M1.5M823.0K663.8K630.6K
Total Current Liabilities581.0K550.1K659.4K718.8K1.6M957.1K
Total Stockholder Equity1.8M1.1M(113.5K)(1.9M)(3.1M)(2.9M)
Property Plant And Equipment Net64.8K327.6K252.8K248.2K256.9K138.0K
Net Debt(232.9K)112.3K764.9K1.8M3.0M3.1M
Retained Earnings(40.3M)(42.4M)(45.0M)(47.5M)(50.6M)(48.1M)
Accounts Payable67.8K190.1K278.5K288.2K330.4K214.2K
Cash570.4K359.4K420.9K296.6K219.0K381.1K
Non Current Assets Total95.9K359.4K252.8K248.2K256.9K256.8K
Cash And Short Term Investments1.9M1.4M920.9K219.0K251.9K239.3K
Net Receivables321.4K175.7K324.2K50.2K166.6K158.2K
Common Stock Shares Outstanding63.1M68.7M69.6M70.6M72.8M76.5M
Liabilities And Stockholders Equity2.4M2.0M1.5M663.8K763.4K725.2K
Other Stockholder Equity8.5M8.8M9.2M9.7M11.1M8.9M
Total Liab614.8K818.2K1.7M2.8M3.7M1.9M
Total Current Assets2.3M1.6M1.3M574.8K406.9K386.5K
Accumulated Other Comprehensive Income8.5M8.8M9.2M9.9M11.4M11.9M
Short Long Term Debt Total337.6K471.7K1.2M3.2M3.7M2.7M
Other Current Liab205.2K152.3K184.2K6.7K191.3K162.6K
Short Term Debt303.8K203.6K190.1K1.1M1.3M897.8K
Short Term Investments86.0K555.7K1.3M1.0M500K0.0
Non Current Liabilities Total33.7K268.1K995.7K2.1M2.1M1.6M
Common Stock33.7M34.8M35.7M35.9M37.7M26.7M
Inventory(21.7K)118.5K32.8K28.8K33.1K43.6K
Other Current Assets26.1K21.7K14.9K20.5K21.3K27.6K
Net Tangible Assets(5.1M)1.8M1.1M(113.5K)(130.5K)(137.1K)
Short Long Term Debt1.7M268.5K125K168.9K975.9K971.4K
Property Plant Equipment64.8K327.6K252.8K248.2K285.5K183.0K
Capital Lease Obligations69.1K307.5K229.2K235.9K263.9K174.4K
Net Invested Capital2.1M1.3M843.1K120.4K(130.2K)(123.7K)
Net Working Capital1.8M1.0M629.4K(144.0K)(1.2M)(1.2M)
Capital Stock33.7M34.8M35.7M35.9M37.7M36.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Diagnos Stock Analysis

When running Diagnos' price analysis, check to measure Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnos is operating at the current time. Most of Diagnos' value examination focuses on studying past and present price action to predict the probability of Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnos' price. Additionally, you may evaluate how the addition of Diagnos to your portfolios can decrease your overall portfolio volatility.